Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 19INDUSTRY 3OTHER_GOV 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Neoplasms 1Malnutrition 1Hepatitis C, Chronic 1Fibrosis 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Dietary Supplements × Clear all
NCT07199556 2025-10-03

DOLFLEX

Arafarma Group, S.A.

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

NCT05495360 2025-02-19

OMENS

Nutricia Research

Phase NA Completed
48 enrolled

Neoplasms, Malnutrition

NCT00502086 2011-02-11

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Catalysis SL

Phase 3 Completed
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡